FOLH1 and neoplasm: [161 Tb]Tb-PSMA-617 reduced the viability and survival of PSMA-expressing PC-3 PIP tumor cells more than twice as effectively as [177Lu]Lu-PSMA-617 (Mueller et al. 2019).